GAIM Ops Cayman
April 23 - 26, 2023
The Ritz-Carlton, Grand Cayman

Alixandra Smith
Chief of Business and Securities Fraud at U.S. Department of Justice


Alixandra Smith is the Chief of the Business and Securities Fraud Section at the United States Attorney’s Office for the Eastern District of New York (“EDNY”).  She has investigated and prosecuted a wide variety of criminal matters against both individuals and entities, including fraud involving publicly-traded companies, market manipulation, insider trading, healthcare fraud, tax crimes, money laundering, cyber-enabled crime and violations of the Foreign Corrupt Practices Act (“FCPA”).  Alix is also an adjunct professor at New York University Law School.

During her time at the Office, Alix has worked on significant white collar cases.  For example, Alix was the co-lead prosecutor on the case United States v. Martin Shkreli and Evan Greebel, in which a pharmaceutical executive and his attorney were charged with securities fraud, wire fraud conspiracy and securities fraud conspiracy in connection with four complex fraud schemes.  Both defendants were tried and convicted in separate trials lasting a combined total of 17 weeks in 2017.  In addition, Alix led the Office’s team that, along with the Department of Justice’s Fraud Section, investigated and prosecuted United States v. Odebrecht and United States v. Braskem, collectively one of the largest foreign bribery cases in history.  In that case, Brazilian-based companies Odebrecht and Braskem pled guilty to conspiracy to violate the FCPA for their roles in a bribery scheme that involved payments of close to a billion dollars over a 15-year period to foreign government officials in Brazil and twelve other countries to obtain and retain business in those countries.  Alix was also the lead criminal prosecutor for United States v. AmerisourceBergen Specialty Group, in which a subsidiary of a major pharmaceutical company pled guilty to a violation of the Federal Food, Drug and Cosmetics Act for the illegal distribution of misbranded oncology drugs, and paid a total of $885 million in criminal and civil penalties. 

Prior to joining the Office, Alix was an associate at two law firms in New York; completed clerkships with the Honorable Julio M. Fuentes, United States Court of Appeals for the Third Circuit, and the Honorable Faith S. Hochberg, United States District Court for the District of New Jersey; and served as an adjunct professor at Fordham Law School.  She graduated from Harvard University and Harvard Law School.

Agenda Sessions

  • Regulators on the real stories influencing enforcement in 2021